Search

everythinglearnresearchcommunity

for

Search:↓

Long-COVID has diverse, long-term health impacts, especially in young people.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Human hair keratins can be turned into useful 3D biomedical scaffolds through a freeze-thaw process.

Low levels of vitamin B12, ferritin, and calcium are linked to premature graying of hair.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

PRP injections improve hair thickness for baldness.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A new gene, JMJD1C, may affect testosterone levels in men.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Melatonin improved mental health and metabolism in women with PCOS.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Facial plastic surgery has evolved to focus on less invasive techniques and innovative technologies for cosmetic and reconstructive procedures.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.